1 |
Morelli P, De Alessandri A, Manno G, et al. Characterization of Staphylococcus aureus small colony variant strains isolated from Italian patients attending a regional cystic fibrosis care centre[J]. New Microbiol, 2015,38(2):235-243.
|
2 |
Proctor RA, Kriegeskorte A, Kahl BC, et al. Staphylococcus aureus Small Colony Variants (SCVs): a road map for the metabolic pathways involved in persistent infections[J]. Front Cell Infect Microbiol, 2014,4:991-998.
|
3 |
Bui LM, Turnidge JD, Kidd SP. The induction of Staphylococcus aureus biofilm formation or Small Colony Variants is a strain-specific response to host-generated chemical stresses[J]. Microbes Infect, 2015,17(1):77-82.
|
4 |
Josten M, Dischinger J, Szekat C, et al. Identification of agr-positive methicillin-resistant Staphylococcus aureus harbouring the class A mec complex by MALDI-TOF mass spectrometry[J]. Int J Med Microbiol, 2014,304(8):1018-1023.
|
5 |
Proctor RA, von Eiff C, Kahl BC, et al. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections[J]. Nat Rev Microbiol, 2006,4(4):295-305.
|
6 |
Masoud-Landgraf L, Zarfel G, Kaschnigg T, et al. Analysis and characterization of Staphylococcus aureus Small Colony Variants Isolated from Cystic Fibrosis Patients in Austria[J]. Curr Microbiol, 2016,72(5):606-611.
|
7 |
Yagci S, Hascelik G, Dogru D, et al. Prevalence and genetic diversity of Staphylococcus aureus smallcolony variants in cystic fibrosis patients[J]. Clin Microbiol Infect, 2013,19:77-84.
|
8 |
von Eiff C. Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians[J]. Int J Antimicrob Agents, 2008,31(6):507-510.
|
9 |
Crompton MJ, Dunstan RH, Macdonald MM, et al. Small changes in environmental parameters lead to alterations in antibiotic resistance, cell morphology and membrane fatty acid composition in Staphylococcus lugdunensis[J]. PLoS One, 2014,9(4):e92296.
|
10 |
Lannergård J, von Eiff C, Sander G, et al. Identification of the genetic basis for clinical menadione-auxotrophic small-colony variant isolates of Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2008,52:4017-4022.
|
11 |
Dean MA, Olsen RJ, Long SW, et al. Identification of point mutations in clinical Staphylococcus aureus strains that produce small colony variants auxotrophic for menadione[J]. Infect Immun, 2014,82:1600-1605.
|
12 |
Mayfield JA, Hammer ND, Kurker RC, et al. The chlorite dismutase (HemQ) from Staphylococcus aureus has a redox-sensitive heme and is associated with the small colony variant phenotype[J]. J Biol Chem, 2013,288(32):23488-23504.
|
13 |
Peschel A, Otto M. Phenol-soluble modulins and staphylococcal infection[J]. Nat Rev Microbiol, 2013,11(10):667-673.
|
14 |
Gagnaire J, Dauwalder O, Boisset S, et al. Detection of Staphylococcus aureus delta-toxin production by whole-cell MALDI-TOF mass spectrometry[J]. PLoS One, 2012,7(7):e40660.
|
15 |
Cervantes-García E, García-Gonzalez R, Reyes-Torres A, et al. Staphylococcus aureus small colony variants in diabetic foot infections[J]. Diabet Foot Ankle, 2015,6:26431-26435.
|
16 |
俞静,刘瑛,陈峰. 甲氧西林耐药的CO2依赖型金黄色葡萄球菌小菌落突变株的分离和鉴定[J]. 上海交通大学学报(医学版), 2012,32(10):1338-1342.
|
17 |
Valour F, Rasigade JP, Trouillet-Assant S, et al. Delta-toxin production deficiency in Staphylococcus aureus: a diagnostic marker of bone and joint infection chronicity linked with osteoblast invasion and biofilm formation[J]. Clin Microbiol Infect, 2015,21(6):568.e1-11.
|
18 |
Pader V, James EH, Painter KL, et al. The Agr quorum-sensing system regulated fibronectin binding but not hemolysis in the absence of a functional electron transport chain[J]. Infect Immun, 2014,82:4337-4347.
|
19 |
Lenhard JR, vonEiff C, HongI S, et al. Evolution of Staphylococcus aureus under vancomycin selective pressure: the role of the small-colony variant phenotype[J]. Antimicrob Agents Chemother, 2015,59(2):1347-1351.
|
20 |
Côté-Gravel J, Brouillette E, Obradović N, et al. Characterization of a vraG mutant in a genetically stable staphylococcus aureus small-colony variant and preliminary assessment for use as a live-attenuated vaccine against intrammamary infections[J]. PLoS One, 2016,11(11):e0166621.
|